Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Cipla
Healthtrust
Baxter
McKinsey
Cerilliant
Express Scripts
Julphar

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206039

« Back to Dashboard

NDA 206039 describes MAGNESIUM SULFATE, which is a drug marketed by Exela Pharma Scs Llc, Fresenius Kabi Usa, Hospira, Hospira Inc, and Hq Spclt Pharma, and is included in ten NDAs. It is available from ten suppliers. Additional details are available on the MAGNESIUM SULFATE profile page.

The generic ingredient in MAGNESIUM SULFATE is magnesium sulfate. There are one hundred and thirty-eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
Summary for 206039
Tradename:MAGNESIUM SULFATE
Applicant:Exela Pharma Scs Llc
Ingredient:magnesium sulfate
Patents:0
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 206039
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MAGNESIUM SULFATE magnesium sulfate SOLUTION;INTRAMUSCULAR, INTRAVENOUS 206039 ANDA X-GEN Pharmaceuticals, Inc. 39822-4025 N 39822-4025-2
MAGNESIUM SULFATE magnesium sulfate SOLUTION;INTRAMUSCULAR, INTRAVENOUS 206039 ANDA Exela Pharma Sciences, LLC 51754-1000 N 51754-1000-4

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAMUSCULAR, INTRAVENOUSStrength5GM/10ML (500MG/ML)
Approval Date:Dec 18, 2014TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Johnson and Johnson
Baxter
Argus Health
Fish and Richardson
McKinsey
Colorcon
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.